Analysis-Prices for new US drugs rose 35% in 2023, more than the previous year
By Deena Beasley (Reuters) – Pharmaceutical companies last year launched new U.S. drugs at prices 35% higher than in 2022,…
By Deena Beasley (Reuters) – Pharmaceutical companies last year launched new U.S. drugs at prices 35% higher than in 2022,…
By Echo Wang and Lance Tupper NEW YORK (Reuters) -Shares of Lotus Technology closed up 2% in their Nasdaq debut…
By David French (Reuters) – The S&P 500 and Dow Jones Industrial Average eked out another closing record high on…
(Reuters) -Canada’s main stock index gained on Friday, wrapping up the week on a positive note, helped by gains in…
By Aditya Soni and Patturaja Murugaboopathy (Reuters) -Nvidia briefly hit $2 trillion in market value for the first time on…
By Niket Nishant and Manya Saini (Reuters) -Reddit disclosed on Thursday that its net loss narrowed to $90.8 million and…
(Reuters) -Shares of Carvana surged nearly 40% on Friday after the used-car retailer posted its first annual profit, in a…
By David French (Reuters) -The S&P 500 and Dow Jones Industrial Average both surged to record closing highs on Thursday,…
By Bhanvi Satija (Reuters) -Carvana reported its first-ever annual profit on Thursday, helped by its pact with bondholders to cut…
By Hannah Lang (Reuters) -Shares in Jack Dorsey-led Block surged 12% on Thursday after the payments firm forecast adjusted core…